The Central Drugs Standard Control Organisation (CDSCO) has allowed import of drugs to India with less than 60% residual shelf life on the condition that importers give an undertaking that the drug would be used or consumed before the expiry date, as reported The Economic Times on Sunday.
"In the light of the present situation due to the COVID-19 outbreak, the health ministry has instructed to take various steps in order to ensure availability of a sufficient quantity of drugs in the domestic retail market, besides ensuring that the product conform to be of the prescribed specification," the Drug Controller General of India (DCGI) said.
"One of the steps is issuing immediate approvals to applications for registration, manufacture and import of pharmaceuticals," the DCGI added.
"Further, we have received a representation from the industry association that there are challenges in the clearance at port offices due to the COVID-19 outbreak and many products are losing their shelf life and getting below the threshold of 60%," the DCGI said.
To read more NewsPoints articles, click here.